Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $33.7B |
| FY2017, ended Dec 31, 2017 | $3.87M |
| FY2018, ended Dec 31, 2018 | $85.0B |
| FY2019, ended Dec 31, 2019 | $113B |
| FY2020, ended Dec 31, 2020 | $138B |
| FY2021, ended Dec 31, 2021 | $176B |
| FY2022, ended Dec 31, 2022 | $161B |
| FY2023, ended Dec 31, 2023 | $198B |
| FY2024, ended Dec 31, 2024 | $198B |
| FY2025, ended Dec 31, 2025 | $198B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $239B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.5B |
| FY2017, ended Dec 31, 2017 | $11.4B |
| FY2018, ended Dec 31, 2018 | $14.8B |
| FY2019, ended Dec 31, 2019 | $28.2B |
| FY2020, ended Dec 31, 2020 | $27.2B |
| FY2021, ended Dec 31, 2021 | $30.8B |
| FY2022, ended Dec 31, 2022 | $33.4B |
| FY2023, ended Dec 31, 2023 | $32.9B |
| FY2024, ended Dec 31, 2024 | $33.0B |
| FY2025, ended Dec 31, 2025 | $34.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $35.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.50B | $1.32B |
| FY2017, ended Dec 31, 2017 | $1.25B | $1.73B |
| FY2018, ended Dec 31, 2018 | $4.38B | $1.77B |
| FY2019, ended Dec 31, 2019 | $2.29B | $2.44B |
| FY2020, ended Dec 31, 2020 | $2.50B | $4.03B |
| FY2021, ended Dec 31, 2021 | $3.83B | $6.64B |
| FY2022, ended Dec 31, 2022 | $4.15B | $5.69B |
| FY2023, ended Dec 31, 2023 | $6.20B | $5.52B |
| FY2024, ended Dec 31, 2024 | $6.57B | $4.93B |
| FY2025, ended Dec 31, 2025 | $6.90B | $5.09B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.24B | $4.97B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $524M |
| FY2017, ended Dec 31, 2017 | $617M |
| FY2018, ended Dec 31, 2018 | $4.47B |
| FY2019, ended Dec 31, 2019 | $2.70B |
| FY2020, ended Dec 31, 2020 | $3.75B |
| FY2021, ended Dec 31, 2021 | $2.82B |
| FY2022, ended Dec 31, 2022 | $5.44B |
| FY2023, ended Dec 31, 2023 | $4.66B |
| FY2024, ended Dec 31, 2024 | $4.85B |
| FY2025, ended Dec 31, 2025 | $5.06B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.90B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | $9.00B |
| FY2018, ended Dec 31, 2018 | $15.3B |
| FY2019, ended Dec 31, 2019 | $14.0B |
| FY2020, ended Dec 31, 2020 | $16.2B |
| FY2021, ended Dec 31, 2021 | $14.2B |
| FY2022, ended Dec 31, 2022 | $17.9B |
| FY2023, ended Dec 31, 2023 | $19.4B |
| FY2024, ended Dec 31, 2024 | $21.6B |
| FY2025, ended Dec 31, 2025 | $27.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $28.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 60.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 288M |
| FY2017, ended Dec 31, 2017 | 25.0K |
| FY2018, ended Dec 31, 2018 | 545M |
| FY2019, ended Dec 31, 2019 | 533M |
| FY2020, ended Dec 31, 2020 | 523M |
| FY2021, ended Dec 31, 2021 | 508M |
| FY2022, ended Dec 31, 2022 | 492M |
| FY2023, ended Dec 31, 2023 | 482M |
| FY2024, ended Dec 31, 2024 | 473M |
| FY2025, ended Dec 31, 2025 | 463M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 461M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $228M | $39.0M | $139M | — |
| FY2017, ended Dec 31, 2017 | $12.0M | $59.0M | $120M | — |
| FY2018, ended Dec 31, 2018 | $599M | $62.0M | $77.0M | $48.4B |
| FY2019, ended Dec 31, 2019 | $2.66B | $95.0M | $72.0M | — |
| FY2020, ended Dec 31, 2020 | $2.46B | $133M | $47.0M | — |
| FY2021, ended Dec 31, 2021 | $4.61B | $128M | $50.0M | — |
| FY2022, ended Dec 31, 2022 | $5.17B | $107M | $36.0M | — |
| FY2023, ended Dec 31, 2023 | $3.96B | $141M | $33.0M | — |
| FY2024, ended Dec 31, 2024 | $4.48B | $160M | $31.0M | — |
| FY2025, ended Dec 31, 2025 | $4.60B | $164M | $23.0M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.06B | $136M | $30.0M | — |
Valuation
At current price- Market Cap
- $234B
- P/E
- 32.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.6×
- Price / Book
- 6.0×
- EV / EBITDA
- 19.5×
Growth
Trailing 12 months- Revenue (TTM)
- $35.4B
- Revenue Growth YoY
- 6.6%
- Revenue CAGR 3Y
- 0.6%
- Revenue CAGR 5Y
- 4.5%
- EPS Growth YoY
- 10.2%
- Net Income Growth YoY
- 7.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 26.5%
- Net Margin
- 20.4%
- FCF Margin
- 14.0%
- Return on Equity
- 18.7%
Earnings
Trailing 12 months- Net Income
- $7.24B
- EPS (diluted)
- $15.50
- EBITDA
- $13.2B
- Operating Income
- $9.38B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.90B
- Total Debt
- $28.0B
- Net Debt
- $23.1B
- Total Assets
- $88.3B
- Total Liabilities
- $47.7B
- Shareholders' Equity
- $39.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.5B
- Capital Expenditure
- $5.51B
- Free Cash Flow
- $4.97B
Dividends and risk
Last 12 months- Dividend Yield
- 1.2%
- Dividend / Share
- $6.30
- Beta (5Y)
- 0.70
Every ratio is calculated from the company’s reported figures.